You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 14 No. 2, February 1966 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effects of a Vasoactive Drug (Nylidrin HCl) on the Response of the Electroencephalogram to Hyperventilation

JULIUS KOREIN, MD; MARTIN GELLER, MD; WILLIAM I. ROSENBLUM, MD; LUCIE LEVIDOW

Arch Neurol. 1966;14(2):202-207.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

HYPERVENTILATION (HV) may cause slowing of the electroencephalogram (EEG) in human subjects. The physiological basis of the response has been the object of considerable debate for several decades.1-8 More recent investigations from several sources favor the hypothesis that sufficient HV causes a decreased blood Pco2 with subsequent cerebral vasoconstriction more marked in the younger age group. This is followed by a significant decrease in cerebral blood flow resulting in cerebral ischemia. The anoxia has been shown to be the factor most highly correlated with the slowing of the EEG in HV.8 The present study was performed in an attempt to evaluate the response to HV of normal subjects utilizing a vasoactive drug. If the hypothesis described above is correct, prevention of vasoconstriction would decrease the production of slow activity by HV.

Nylidrin HC1 is the vasoactive agent used. This agent increases extracranial and cerebral blood flow . . . [Full Text PDF of this Article]


Author Affiliations

NEW YORK

From the departments of psychiatry and neurology and the Department of Pathology, New York University Medical Center, New York.


Footnotes

Submitted for publication Sept 3, 1965; accepted Oct 10.

Reprint requests to the Department of Psychiatry & Neurology, New York University Medical Center, New York 10016 (Dr. Korein).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1966 American Medical Association. All Rights Reserved.